
Minimally Invasive Interventional Device Developer
From December 12th to 14th, the Shenzhen International High-Performance Medical Device Exhibition grandly opens, gathering cutting-edge technologies and products in the industry. Valgen Medtech sincerely invites you to visit Booth 4C37 in Hall 4 to explore the new face of advanced productivity and witness the extraordinary charm of medical technology together.


Valgen Medtech Co., Ltd. was established in 2015 and focuses on interventional treatment products and technologies for mitral and tricuspid valve diseases. The company has applied for over 600 patents globally, with more than 200 already granted. Four innovative products independently developed by the company have passed the special review process for innovative medical devices by the pharmaceutical regulatory authority. Its range of interventional treatment devices, represented by the Dragon series, will greatly enrich clinical options in China for treating structural heart disease.
Core Product DragonFly™ Transcatheter Mitral Valve Clip System – As the first China-developed transvenous edge-to-edge repair product in China, it has been approved by the NMPA for official launch in China. The product is supported by the national "14th Five-Year Plan" key R&D project. In addition, other currently marketed products include Sister Pu™ Medical Radiation Protection Screen, Magpie™ Balloon Dilation Catheter, DragonPath™ Atrial Septal Puncture System, and a series of guidewires.